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Innate lymphoid cells (ILCs) and T helper (Th) cells share similar effector functions. In this issue of Immunity,
Hoyler et al. (2012) and Mjosberg et al. (2012) demonstrate that GATA-3, a Th2 regulator, controls ILC2 differ-
entiation, maintenance, and function.Innate lymphoid cells (ILCs) represent an
emerging family of cell types, including
natural killer (NK) cells, type 2 ILCs
(ILC2s), and RORgt+ ILCs that play key
roles in tissue remodeling and innate
immunity, particularly at barrier surfaces.
These cells are characterized by a
lymphoid morphology and an absence of
T cell receptors but can secrete a variety
of effector cytokines that are also
produced by T helper (Th) cell subsets.
The transcription factor Id2 is required
for all innate lymphoid cell development.
However, the development of ILCs is
independent of the genes that encode
the Rag protein and thus ILCs are abun-
dantly present in Rag-deficient mice
(Spits and Cupedo, 2012). Unlike RORgt+
ILCs, ILC2 cells do not express RORgt but
express type 2 helper T (Th2) cell-related
cytokines (e.g., interleukin-13 [IL-13],
IL-5, and IL-4). ILC2s are involved in
protective immunity against helminth
infection (e.g.,N. brasiliensis) and in tissue
repair after influenza virus infection,
whereas dysregulation of ILC2s may
lead to inflammation and autoimmunity
(e.g., allergic airway inflammation) (Chang
et al., 2011; Monticelli et al., 2011; Moro
et al., 2010; Neill et al., 2010; Price et al.,
2010; Saenz et al., 2010).
Previous data suggest that ILCs and Th
cells share a number of common features
(e.g., transcription factor requirement,
cytokine profile, and anatomic location).
As an example, both RORgt+ ILCs and
Th17 cells require nuclear receptor RORgt
for their differentiation and/or develop-
ment and function. Accordingly, RORgt-
deficient mice lack RORgt+ ILCs and
have marked reduction of Th17 cells.
Both RORgt+ ILCs and Th17 cells
produce IL-17 and/or IL-22, are abun-dantly present in mucosal tissues,
and are involved in similar immune
functions (e.g., clearance of Citrobacter
rodentium) (Spits and Cupedo, 2012).
It is logical to hypothesize that other
ILC populations (e.g., ILC2) may also
share similar transcriptional programs
with their corresponding Th cells (e.g.,
Th2 cells). In this issue of Immunity, Hoyler
et al. (2012) and Mjosberg et al. (2012)
show that, indeed, similar to RORgt
for RORgt+ ILC lineage specification,
GATA-3 is a bona fide regulator of ILC2
development and function.
Using elegant genetic and cellular
approaches, Hoyler et al. (2012) demon-
strated that GATA-3, an important
Th2 cell regulator, is a critical transcrip-
tion factor for ILC2 lineage specification
and maintenance (Figure 1). High
GATA-3 expression was detected in
bone marrow (BM) progenitor cells that
are LinSca1hiId2hi (LSIG). Gene profiling
analysis indicated a close relationship
between LSIG and ILC2. LSIG can give
rise to mature ILC2 that express high
amounts of the lectin-like receptor
KLRG1 in vitro and in vivo. Using an OP9
cell system, Hoyler et al. (2012) further
showed that even under conditions that
favor the development of other ILC line-
ages (e.g., NK or RORgt+ ILCs), LSIG
seemed to be ‘‘prewired’’ for ILC2
programming, suggesting their limited
plasticity at least in vitro. LSIG after trans-
ferring into alymphoid Rag2/Il2rg/
mice proliferated and developed into
mature ILC2s, which were functional in
gut immunity against helminth infection
(e.g., N. brasiliensis). Thus, LSIG popula-
tions in the bone marrow represent
lineage-specified precursors to ILC2
(i.e., ILC2P).Immunity 37Using an inducible Cre-Lox system
(Gata3f/f Id2CreERt2) to temporally ablate
GATA-3 in Id2+ cells including all ILCs
and T cells by administration of tamoxifen,
the authors further showed that contin-
uous expression of GATA-3 is essential
for the maintenance of mature ILC2 and
their effector functions. Temporal deletion
of GATA-3 also affected the ILC2 pro-
genitor pool in the bone marrow, sug-
gesting that GATA-3 is required for
the maintenance of ILC2P. Culturing
GATA-3-deficient LinCD25+Sca1high
progenitors failed to generate mature
ILC2 in vitro, indicating that GATA-3 is
essential for differentiation of ILC2P to
ILC2. These data collectively demon-
strate that GATA-3 expression is crucial
for the development and maintenance of
ILC2 lineage.
Intriguingly, adoptive transfer experi-
ments suggest that ILC2Ps migrate to
the intestine preferentially before matura-
tion to ILC2s, consistent with the expres-
sion of gut homing receptor CCR9 on
ILC2P. Given that substantial numbers of
intestinal ILC2 were found in CCR9-defi-
cient animals, these data argue that addi-
tional mechanisms besides CCR9 (e.g.,
the presence of integrin a4b7 required
for lymphocyte gut homing and/or reten-
tion) may account for the apparent gut
homing property of ILC2Ps. Unexpect-
edly, the expression of integrin a4b7 actu-
ally declined in mature ILC2s when mice
aged, suggesting that other adhesion
molecules than a4b7 may be required for
the retention of mature ILC2s in the
intestine of adult mice. Consistent with
this notion, KLRG1, uniformly expressed
by intestinal ILC2s in adult mice at high
levels, binds to classical cadherins,




















Figure 1. GATA-3 Is Essential for ILC2 Development and Function in Mice
GATA-3 determines the lineage specification of ILC2. GATA-3 is not only important for the maturation of ILC2P but also essential for the maintenance of ILC2P
and mature ILC2. Bone marrow resident progenitors contain a population of cells that are LinSca1hiId2hi. These cells have high expression of GATA-3 and Id2
and show similar gene profile to mature ILC2, thus representing ILC2-specific progenitors (ILC2P). After adoptive transfer, ILC2P cells migrate to the gut pref-
erentially and differentiate into functional ILC2 with production of effector cytokines (IL-13, IL-5, and IL-4), consistent with the expression of gut homing receptor
CCR9. Mature ILC2 cells in the gut do not express a4b7 but upregulate KLRG1. ILC2 cytokines stimulate gut epithelial cells to produce protective factors (e.g.,
angiogenin and mucin) to control helminth infection.
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Previewsexpressed by intestinal epithelial cells.
The role of KLRG1 in recruitment, reten-
tion, and function of ILC2 remains to be
determined in future studies. Of note,
the number of ILC2 was prominent in the
lamina propria of intestine under the
steady state. However, during inflamma-
tion or infection (e.g., IL-25, IL-33 injec-
tion, or N. brasiliensis infection), ILC2
numbers significantly increased in other
organs (e.g., the lung, liver, and spleen).
It remains to be determined whether this
increase of ILC2 in extraintestinal sites
represents an enhanced recruitment
(e.g., active diversion of ILC2 from the
gut to other organs), increased prolifera-
tion and/or survival of other tissue resi-
dent ILC2, and/or facilitated de novo
differentiation of ILC2P in situ.
Using gain-of-function approach (over-
expression by retroviral transduction) and
loss-of-function approach (gene silencing
by short-hairpin RNA), Mjosberg et al.
delineated the signaling pathways that
regulate ILC2 function and convincingly
showed that GATA-3 is essential for
the production of type 2 cytokines (e.g.,
IL-13, IL-5, and IL-4) by human ILC2s.
ILC2, defined as LinCD127+CRTH2+
in humans, are highly enriched in inflamed
nasal polyps of patients with chronic rhi-590 Immunity 37, October 19, 2012 ª2012 Elnosinusitis (CRS). Interestingly, although
the TSLP-TSLPR axis is dispensable for
intestinal ILC2 development and/or main-
tenance in mice, it is important for the
function of human ILC2 (Hoyler et al.,
2012). Consistent with the potential role
of microbes in CRS pathogenesis, various
TLR ligands activated nasal polyp epithe-
lial cells to increase Tslp and Il33 gene
expression. TSLP and IL-33 produced
by epithelial cells in turn act on ILC2 by
binding to TSLP receptor (TSLPR) and
IL-33 receptor subunit (ST2), respectively.
The authors further showed that TSLP
activated STAT5 but not STAT3 to
markedly enhance GATA-3 expression.
Although IL-33 acts synergistically with
TSLP to induce ILC2 effector cytokines
(e.g., IL-13, IL-5, and IL-4), it seemed to
have less of an effect on GATA-3 induc-
tion. It has been shown that IL-33
enhances ILC2 proliferation and function,
but the signaling pathways underlying
these processes remain to be determined
(Neill et al., 2010; Price et al., 2010). It
is of special interest to determine how
the synergy between TSLP (e.g., via
JAK-STAT pathway) and IL-33 (e.g.,
via NF-kB and AP-1 pathways) is
achieved in the induction of ILC2 effector
cytokines.sevier Inc.It is interesting to note that ectopic
expression of GATA-3 in LinCD127+
CD117+NKp44CRTH2 cells by retro-
viral transduction resulted in the induction
of surface marker of human ILC2 and Th2
cells, CRTH2. However, overexpression
of GATA-3 was not able to directly induce
ILC2 effector cytokines, which required
additional stimulation of GATA-3-ex-
pressing cells with IL-33, TSLP, and
IL-2. Consistently, expression of TSLPR
and ST2 was significantly enhanced by
GATA-3 overexpression. These data
suggest a positive amplifying mechanism
underlying effector function of ILC2.
Induction of GATA-3 by TSLP upregulates
TSLPR and ST2, resulting in the ability of
ILC2 to respond to TSLP and IL-33 for
further enhancement of GATA-3. The
additional requirement of TSLP and IL-33
for induction of ILC2 effector cytokines
suggests that factor(s) induced by TSLP
and/or IL-33 may function cooperatively
with GATA-3 to induce effector cytokine
gene transcription. It is tempting to specu-
late that a permissive chromatin structure
set up by TSLP and/or IL-33 at the IL13,
IL5, or IL4 loci in ILC2 may be required
for GATA-3 binding and transactivation.
ILC2 were recently shown to depend
on the transcription factor RORa (Halim
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Previewset al., 2012; Wong et al., 2012). Both Hoy-
ler et al. (2012) and Mjosberg et al. (2012)
showed that the expression of RORa is
not limited to ILC2, thus raising an inter-
esting question about the cell-intrinsic
role of RORa in ILC2. The development
and characterization of RORa mice with
ILC-specific deletion will help elucidate
the role of RORa in the future. Although
it was shown that RORA transcription is
not regulated by GATA-3 (Mjosberg
et al., 2012), it remains to be determined
whether RORa works in parallel to inter-
play with GATA-3 (e.g., by protein-protein
interaction), thereby promoting ILC2
development and function.
ILCs share a striking similarity to Th
cells in effector cytokine production.
Coevolution of two systems may be a
fail-safe mechanism to implement redun-
dancy in host immunity against certain
infections especially at the mucosal sur-
faces. Active cross-regulation between
individual ILCs and Th cells may also be
present in the host. Recent data suggest
that Th cells can display significant plas-ticity in certain conditions (e.g., during
infection and inflammation). It remains to
be determined whether this plasticity is
also associated with ILCs. Collectively,
the two papers published in the issue
shed novel light on the ILC biology and
demonstrate that ILC2 and Th2 cells
share the same master transcriptional
regulator GATA-3.REFERENCES
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In this issue of Immunity, Zhu et al. (2012) report amouse reporter strain for the transcription factor T-bet. This
reagent provides for the resolution of some longstanding issues in T helper cell development.A reagent reported in this issue of
Immunity sheds new light on some long-
standing and unresolved issues in T
helper (Th) cell development. Dr. William
E. Paul’s group describes the generation
and analysis of a green fluorescent pro-
tein reporter for the ‘master’ transcription
factor T-bet (Tbx21). T-bet is critical for
development of the Th1 cells that
generate the pleiotropic cytokine inter-
feron-g (IFN-g) needed in defense against
many intracellular pathogens. Although
a major role of T-bet in Th1 cell differenti-
ation has been appreciated for a decade,and although the initiating factors that
trigger Th1 cell development have been
appreciated for nearly two decades,
important issues have remained unre-
solved. Certain gaps, stemming more
from experiments that were never done
rather than unresolved experimental dis-
crepancies, have persisted as loose
threads left behind as people have moved
on to other topics. Fortunately, Dr. Paul,
who has worked in this area from its
beginning, has remained centrally fo-
cused on these gaps and now addresses
several longstanding issues by using anewly generated T-bet-ZsGreen reporter
mouse.
After the discovery of distinct CD4+
T cell effector subsets—from an in vitro
examination of T cell clones—the next
question was whether and how these
subsets developed in vivo in a normal
physiologic setting. The first physiologic
trigger was described for Th1 cell differ-
entiation; this trigger was the induction
of the cytokine IL-12 by Listeria monocy-
togenes from macrophages and dendritic
cells (Hsieh et al., 1993). Later, the tran-
scription factor STAT4 was found to be, October 19, 2012 ª2012 Elsevier Inc. 591
